Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer

Our aim was to evaluate the efficacy and safety of cisplatin with pemtrexed or vinorelbine and concurrent late course accelerated hyperfractionated radiotherapy (LCAHRT). Patients with unresectable stage III non-small-cell lung cancer (NSCLC) were randomly assigned to two regimens. The experimental...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Zhao, Qian, Wang, Zhongtang, Huang, Wei, Wang, Qiang, Yu, Shuzeng, Zhou, Tao, Han, Dan, Wu, Zhenying, Gong, Heyi, Sun, Hongfu, Zhang, Jian, Wei, Yumei, Li, Hongsheng, Zhang, Zicheng, Lin, Haiqun, Li, Baosheng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Clinical Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4885003/
https://ncbi.nlm.nih.gov/pubmed/26761213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6871
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller